Ana Maria Mendes Cerdeira, Ph.D., is Vice President, Strategic Planning and Portfolio Strategy of Molecular Partners. Ana brings almost two decades of experience in global business development and strategic portfolio management to the team. Prior to joining Molecular Partners, Ana held several leadership positions at Takeda Pharmaceuticals, most recently serving as Vice President of Emerging Markets Portfolio Management, where she played a key role in defining their portfolio strategy and worked on several product launches, including Adcetris, Ninlaro and Entyvio. Previously, Ana also held several positions at Janssen Pharmaceuticals, including CMC Drug Product Leader and Head of the Formulation Science and Technology Center. She earned a MPharm from the University of Lisbon, Portugal and a Ph.D. from Eidgenössische Technische Hochschule Zürich (ETH Zürich), Switzerland.